Inventor · disambiguated record
Joseph M. Sheridan
Also filed as: SHERIDAN JOSEPH · SHERIDAN JOSEPH M · SHERIDAN JOSEPH MICHAEL
12 granted patents·10 pending applications·27 citations·filing 2001–2024
86Inventor score
Files withELECTROPHORETICS LTD4EVOLVA SA3SpecNova LLC3INT FLAVORS & FRAGRANCES INC2RIVER STONE BIOTECH INC2
Top patents by PatentIndex Score
22 records- 0191US10815514B2Production of steviol glycosides in recombinant hostsEVOLVA SA·Filed 2017·Granted Oct 27, 2020·19 cites·6 claims
- 0283US10815230B2Casein kinase 1 delta inhibitorELECTROPHORETICS LTD·Filed 2016·Granted Oct 27, 2020·3 cites·17 claims
- 0380US11986457B2Nutraceutical compositionsSpecNova LLC·Filed 2022·Granted May 21, 2024·1 cites·8 claims
- 0479US10208293B2Compositions and methods for the biosynthesis of vanillan or vanillin beta-D-glucosideHANSEN JOERGEN·Filed 2012·Granted Feb 19, 2019·3 cites·2 claims
- 0568US10119154B2Anthocyanins with specific propertiesEVOLVA SA·Filed 2013·Granted Nov 6, 2018·1 cites·20 claims
- 0667US11008592B2Compositions and methods for the biosynthesis of vanillin or vanillin beta-d-glucosideINT FLAVORS & FRAGRANCES INC·Filed 2019·Granted May 18, 2021·0 cites·14 claims
- 0767US2025032426A1Pharmaceutical compositionsSpecNova LLC·Filed 2024·Application pending·0 cites
- 0867US2025179543A1Norcoclaurine synthases with increased acitvityRIVER STONE BIOTECH INC·Filed 2024·Application pending·0 cites
- 0966US2024150804A1Demethylation of Reticuline and Derivatives Thereof with Fungal Cytochrome P450RIVER STONE BIOTECH LLC·Filed 2023·Application pending·0 cites
- 1066US2021230646A1Compositions and methods for the biosynthesis of vanillin or vanillin beta-d-glucosideINT FLAVORS & FRAGRANCES INC·Filed 2021·Application pending·0 cites
- 1159US2021155966A1Production of steviol glycosides in recombinant hostsEVOLVA SA·Filed 2020·Application pending·0 cites
- 1256US9763947B2Casein kinase 1delta (CK1delta) inhibitorsELECTROPHORETICS LTD·Filed 2015·Granted Sep 19, 2017·0 cites·9 claims
- 1355US9789111B2Casein kinase 1δ (CK 1δ) inhibitorsELECTROPHORETICS LTD·Filed 2015·Granted Oct 17, 2017·0 cites·8 claims
- 1455US2022296537A1Novel pharmaceutical compositionsSpecNova LLC·Filed 2022·Application pending·0 cites
- 1554US2016354375A1CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES SUCH AS TAUOPATHIESELECTROPHORETICS LTD·Filed 2016·Application pending·0 cites
- 1653US12203118B2Norcoclaurine synthases with increased activityRIVER STONE BIOTECH INC·Filed 2018·Granted Jan 21, 2025·0 cites·18 claims
- 1751US11781164B2Demethylation of reticuline and derivatives thereof with fungal cytochrome P450RIVER STONE BIOTECH LLC·Filed 2018·Granted Oct 10, 2023·0 cites·16 claims
- 1848US2014031547A1CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODE-GENERATIVE DISEASES SUCH AS TAUOPATHIESSHERIDAN JOSEPH M·Filed 2011·Application pending·0 cites
- 1948US2014018540A1Casein kinase 1delta (ck 1delta) inhibitorsSHERIDAN JOSEPH M·Filed 2011·Application pending·0 cites
- 2044US11203628B2CD200 mutants and its usesDUCENTIS BIOTHERAPEUTICS LTD·Filed 2017·Granted Dec 21, 2021·0 cites·19 claims
- 2140US8222254B21, 2, 4-triazole derivatives as serotonergic modulatorsHEAL JONATHAN RICHARD·Filed 2008·Granted Jul 17, 2012·0 cites·20 claims
- 2239US2004156839A1Antisense peptides to human fc receptors and their usesFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joseph M. Sheridan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →